Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive NonāSmall-Cell Lung Cancer and Brain Metastases in Two Clinical Trials This phase III, open-label study ...
There's one word that most folks would like to see included when reading a description of a personal protection pistol: affordable. Very few factory-fresh defensive handguns are available these days ...
Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and allogeneic stem cell transplantation (HSCT). We evaluated toxicity and efficacy of CPX-351 in 71 elderly patients ...
Liposomal daunorubicin and cytarabine (CPX-351) was effective in relapsed acute myeloid leukemia, but long-term follow-up is needed to determine the extent of the agent's cardiotoxicity. In a study of ...
One innovative entrant into the market of compact, polymer-frame handguns is SCCY Industries (pronounced āskyā) with its CPX-1 and CPX-2 pistols. Both are chambered in the ubiquitous 9 mm Luger ...
Initial evidence of CPX-351 activity in patients younger than 60 years emerged from a phase I trial [1]; however, subsequent pivotal phase III trial focused on older patients (ā„60 years), where ...
Characteristics and outcomes of acute myeloid leukemia (AML) with extramedullary disease (EMD). A phase 2 study of hyper-CVAD plus ofatumumab as frontline therapy in CD20+ acute lymphoblastic leukemia ...
PRINCETON, N.J., June 3 /PRNewswire/ -- Celator Pharmaceuticals reported positive results from its CPX-1 Phase 2 clinical trial in patients with advanced colorectal cancer. CPX-1 is a liposomal ...
PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results